Search results
Why Vaccine Stocks Rallied This Week | The Motley Fool
The Motley Fool· 6 hours agoShares of vaccine stocks Moderna (MRNA 0.85%), Novavax (NVAX 3.17%), and BioNTech SE (BNTX -2.99%)...
Here's how U.S. health officials are responding to bird flu in humans after second case
CNBC· 2 hours agoU.S. health officials are monitoring and preparing to combat bird flu in humans, even as they stress...
Moderna wins a battle in vaccine patent dispute with Pfizer-BioNTech - The Boston Globe
The Boston Globe· 7 days agoModerna said Friday that the European Patent Office has upheld the validity of one of its key...
Pfizer's Path To Profit: A Look At PFE Stock As Drugmaker Rolls Out $1.5B In Cost Reductions - ...
Benzinga· 1 day agoPfizer Inc. PFE has recently launched a multi-year cost reduction initiative aimed at saving...
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
Zacks via Yahoo Finance· 1 day agoThe Biden administration is reportedly in talks with vaccine makers Moderna (MRNA) and Pfizer (PFE)...
3 Stocks That Can Help You to Get Richer in 2025 and Beyond
Motley Fool via Yahoo Finance· 6 hours ago(That's no accident, because a falling stock price will boost a dividend yield, and vice versa, and ...
Penn researchers made an avian flu vaccine using a technique that created COVID vaccines
Philly.com· 1 day agoUniversity of Pennsylvania researchers have developed an mRNA vaccine for the H5N1 avian flu drawing...
Free COVID-19 vaccines could be a thing of the past. Experts weigh in.
USA TODAY via Yahoo News· 2 days agoVaccine manufacturers Novavax and Pfizer said via email they planned to assess their accessibility...
Pfizer (NYSE:PFE) Shares Up 2%
ETF DAILY NEWS· 8 hours agoPfizer Inc. (NYSE:PFE – Get Free Report)’s share price was up 2% during trading on Wednesday . The stock traded as high as $29.18 and last traded at $29.13. Approximately ...
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
Benzinga· 7 days agoModerna Inc MRNA has reportedly achieved a significant victory at the European Patent Office (EPO)...